KNSA Kiniksa Pharmaceuticals International, Plc

Pharmaceutical Preparations · Nasdaq · SEC EDGAR official

Market Value*

$1.11B

Revenue (FY)

$677.56M 2025-12-31

Net Income (FY)

$59.01M

P/E (float-based)

18.9

Financial History annual

Interactive chart · SEC EDGAR annual filings (10-K / 20-F) · enable JavaScript if blank

*Market value = public float disclosed in latest 10-K filing · CIK 1730430 · SEC filings · revenue ranking · home